Bonus Biogroup Asset Resilience Ratio

Latest as of March 2024: 10.04%

Bonus Biogroup asset resilience ratio. Bonus Biogroup (BONS) has an Asset Resilience Ratio of 10.04% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Bonus Biogroup to measure how many days the company can operate on defensive assets alone.

Liquid Assets

ILA3.90 Million

≈ $10.45K USD Cash + Short-term Investments

Total Assets

ILA38.85 Million

≈ $104.16K USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Bonus Biogroup (2008–2015)

Asset resilience ratio of Bonus Biogroup from 2008 to 2015. This chart shows how Bonus Biogroup's Asset Resilience Ratio has changed over time. Read BONS total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Bonus Biogroup's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Bonus Biogroup balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA3.90 Million	10.04%
Total Liquid Assets	ILA3.90 Million	10.04%

Asset Resilience Insights

Moderate Liquidity: Bonus Biogroup has 10.04% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Bonus Biogroup Industry Peers by Asset Resilience Ratio

Compare Bonus Biogroup's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Bonus Biogroup Asset Resilience Ratio by Year (2008–2015)

Bonus Biogroup asset resilience ratio by year from 2008 to 2015. The table below shows the annual Asset Resilience Ratio data for Bonus Biogroup.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2015-12-31	1.88%	ILA108.00K ≈ $289.54	ILA5.76 Million ≈ $15.43K	-20.23pp
2014-12-31	22.11%	ILA1.00 Million ≈ $2.68K	ILA4.52 Million ≈ $12.13K	-42.61pp
2013-12-31	64.72%	ILA5.28 Million ≈ $14.15K	ILA8.16 Million ≈ $21.87K	-12.06pp
2012-12-31	76.78%	ILA6.80 Million ≈ $18.22K	ILA8.85 Million ≈ $23.73K	+71.44pp
2010-12-31	5.34%	ILA324.00K ≈ $868.63	ILA6.07 Million ≈ $16.28K	+0.43pp
2009-12-31	4.90%	ILA2.42 Million ≈ $6.49K	ILA49.39 Million ≈ $132.40K	+0.78pp
2008-12-31	4.13%	ILA2.10 Million ≈ $5.62K	ILA50.81 Million ≈ $136.21K	--

pp = percentage points

About Bonus Biogroup

TA:BONS Israel Biotechnology

Market Cap

$51.35 Million

ILA19.15 Billion ILA

Market Cap Rank

#21613 Global

#288 in Israel

Share Price

ILA16.40

Change (1 day)

+1.23%

52-Week Range

ILA16.20 - ILA58.50

All Time High

ILA171.00